New CFO in Navamedic ASA

23-Sep-2009 - Torbjörn Sannerstedt has been appointed as the new CFO of Navamedic. Before Navamedic, Torbjörn Sannerstedt held the CFO position at AcadeMedia Company. Before AcadeMedia Torbjörn Sannerstedt has worked in different CFO position, but has also experience from executive positions as CEO. Torbjörn ...

New CEO in Navamedic ASA

07-May-2009 - Olof Milveden is appointed new CEO of Navamedic ASA. Olof Milveden has 27 years of experience from the pharma/health care industry. His last position has been that of CEO and Cluster Head Nordic in Sandoz A/S (Denmark). He has working experience from Europe, Asia, Africa and USA. Previous ...

Navamedic concentrates key resources on the development of its Vitaflo business

Company will initiate a process to move main head office functions to Gothenburg

12-Nov-2008 - The Board of Directors of Navamedic ASA has decided to focus the company's further development on its Direct Sales and Marketing business, through the subsidiary Vitaflo Scandinavia AB. The company will initiate a process to move the main management functions currently conducted at the Navamedic ...

Navamedic sells chitin operation - Focus on core strategy

25-Apr-2008 - Navamedic sells ChitiNor AS to Seagarden AS for NOK 2.3 million in shares. The decision is in line with the company's strategy to move from a glucosamine pure-play to a specialty pharma company with a broad product portfolio. While the sale reduces the group's long-term debt by NOK 2 million, it ...

Vitaflo signs new in-licensing agreement for Nordic countries

24-Oct-2007 - Navamedic's fully owned subsidiary Vitaflo Scandinavia AB has signed a new in-licensing agreement with OrphaSwiss GmbH for marketing of two products in Sweden, Denmark, Norway and Finland. The products fall within the knowledge areas pain and alcohol/heroin abusement, respectively. Vitaflo ...

Navamedic ASA completes the acquisition of Vitaflo Scandinavia AB

09-Oct-2007 - On 4 October, Navamedic ASA completed the acquisition of 100% of the shares in the Swedish pharmaceutical company Vitaflo Scandinavia AB, and takes the first step towards the creation of an international speciality pharmaceutical company. To Navamedic, the acquisition of Vitaflo Scandinavia ...

Navamedic ASA acquires Vitaflo Scandinavia AB and initiates a new strategic phase

23-Aug-2007 - Navamedic ASA entered into an agreement with POA Consulting Scandinavia AB concerning the acquisition of the Swedish speciality pharmaceutical company Vitaflo Scandinavia AB at a purchase price of SEK 90 million (enterprise value), of which SEK 54 million shall be settled in cash and the ...

Final agreement between Navamedic and Grünenthal for Glucodmed/Flexove marketing in Mexico

02-May-2007 - Navamedic ASA and Grünenthal GmbH have signed the final agreement for marketing and distribution of Glucomed/Flexove in Mexico. On the 22 February 2007, Navamedic ASA announced that it had entered into a Heads of Agreement with Grünenthal for marketing and distribution of Glucomed/Flexove in ...

Navamedic signs marketing and distribution agreement in Germany

01-Mar-2007 - Navamedic ASA has signed a marketing and distribution agreement with an undisclosed partner in the German market. With this agreement, the company has established a marketing and distribution network of 13 partners covering 25 countries. During February, Navamedic has also received Marketing ...

Navamedic sells chitin to Lytone Enterprise Inc. in Taiwan

21-Mar-2006 - Navamedic ASA has signed a letter of intent (LOI) with Lytone Enterprise Inc. in Taiwan for the sale of the first year's production from the company's planned new chitin factory at Senjahopen in Troms. The LOI between Navamedic's 100% owned subsidiary ChitiNor AS and Lytone Enterprise, Inc. in ...